Clearlife

Antimony Trisulfide, Arnica Montana Root, Euphrasia Stricta,formic Acid,graphite,histamine Dihydrochloride,strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Sulfur, Sulfuric Acid, Tellurium, And Thuja Occidentalis Leafy Twig


Medinatura Inc.
Human Otc Drug
NDC 62795-1028
Clearlife also known as Antimony Trisulfide, Arnica Montana Root, Euphrasia Stricta,formic Acid,graphite,histamine Dihydrochloride,strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Sulfur, Sulfuric Acid, Tellurium, And Thuja Occidentalis Leafy Twig is a human otc drug labeled by 'Medinatura Inc.'. National Drug Code (NDC) number for Clearlife is 62795-1028. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Clearlife drug includes Antimony Trisulfide - 10 [hp_X]/1 Arctium Lappa Root - 8 [hp_X]/1 Arnica Montana Root - 5 [hp_X]/1 Euphrasia Stricta - 6 [hp_X]/1 Formic Acid - 8 [hp_X]/1 Graphite - 10 [hp_X]/1 Histamine Dihydrochloride - 8 [hp_X]/1 Ledum Palustre Twig - 7 [hp_X]/1 Lycopodium Clavatum Spore - 6 [hp_X]/1 Pine Tar - 10 [hp_X]/1 and more. The currest status of Clearlife drug is Active.

Drug Information:

Drug NDC: 62795-1028
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Clearlife
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Antimony Trisulfide, Arnica Montana Root, Euphrasia Stricta,formic Acid,graphite,histamine Dihydrochloride,strychnos Ignatii Seed, Arctium Lappa Root, Ledum Palustre Twig, Lycopodium Clavatum Spore, Pine Tar, Selenium, Sulfur, Sulfuric Acid, Tellurium, And Thuja Occidentalis Leafy Twig
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Medinatura Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANTIMONY TRISULFIDE - 10 [hp_X]/1
ARCTIUM LAPPA ROOT - 8 [hp_X]/1
ARNICA MONTANA ROOT - 5 [hp_X]/1
EUPHRASIA STRICTA - 6 [hp_X]/1
FORMIC ACID - 8 [hp_X]/1
GRAPHITE - 10 [hp_X]/1
HISTAMINE DIHYDROCHLORIDE - 8 [hp_X]/1
LEDUM PALUSTRE TWIG - 7 [hp_X]/1
LYCOPODIUM CLAVATUM SPORE - 6 [hp_X]/1
PINE TAR - 10 [hp_X]/1
SELENIUM - 12 [hp_X]/1
STRYCHNOS IGNATII SEED - 6 [hp_X]/1
SULFUR - 12 [hp_X]/1
SULFURIC ACID - 21 [hp_X]/1
TELLURIUM - 10 [hp_X]/1
THUJA OCCIDENTALIS LEAFY TWIG - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 30 Sep, 2014
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 30 Apr, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 10 Jun, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:MediNatura Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:F79059A38U
597E9BI3Z3
MUE8Y11327
C9642I91WL
0YIW783RG1
4QQN74LH4O
3POA0Q644U
877L01IZ0P
C88X29Y479
YFH4WC535J
H6241UJ22B
1NM3M2487K
70FD1KFU70
O40UQP6WCF
NQA0O090ZJ
1NT28V9397
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
62795-1028-21 BOTTLE in 1 CARTON (62795-1028-2) / 100 TABLET in 1 BOTTLE30 Sep, 201430 Apr, 2025No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antimonium crudum 10x..............................relieves skin rashes arnica montana, radix 6x............................relieves itching skin euphrasia officinalis 6x..............................relieves allergic eye symptoms formicum acidum 8x...................................relieves dry throat graphites 10x.............................................relieves skin irritations histaminum hydrochloricum 8x, 12x, 20x....relieves allergic itch ignatia amara 5x.......................................relieves tickling in throat lappa major 8x..........................................relieves itchy, irritated skin ledum palustre 7x.....................................relieves itchy skin lycopodium clavatum 6x............................relieves nasal congestion pix liquida 10x...........................................relieves itchy skin selenium metallicum 12x...........................relieves skin rashes sulphur 12x...............................................relieves sneezing sulphuricum acidum 21x............................relieves itchy, watery eyes tellurium metallicum 10x...........................relieves itchy eyes thuja occidentalis 6x.................................relieves nasal irritations

Product Elements:

Clearlife antimony trisulfide, arnica montana root, euphrasia stricta,formic acid,graphite,histamine dihydrochloride,strychnos ignatii seed, arctium lappa root, ledum palustre twig, lycopodium clavatum spore, pine tar, selenium, sulfur, sulfuric acid, tellurium, and thuja occidentalis leafy twig antimony trisulfide antimony trisulfide arnica montana root arnica montana root euphrasia stricta euphrasia stricta formic acid formic acid graphite graphite histamine dihydrochloride histamine strychnos ignatii seed strychnos ignatii seed arctium lappa root arctium lappa root ledum palustre twig ledum palustre twig lycopodium clavatum spore lycopodium clavatum spore pine tar pine tar selenium selenium sulfur sulfur sulfuric acid sulfuric acid tellurium tellurium thuja occidentalis leafy twig thuja occidentalis leafy twig lactose magnesium stearate butterfly

Indications and Usage:

Indications and usage for the temporary relief of minor allergy symptoms: runny nose watery eyes skin irritations

Warnings:

Warnings if pregnant or breast-feeding, ask a healthcare provider before use. keep out of reach of children. if symptoms persist or worsen, a healthcare provider should be consulted. do not use if known sensitivity to clearlife™ or any of its ingredients exists.

Dosage and Administration:

Dosage and administration standard dosage: adults and children 12 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours. children 4 to 11 years: 2 tablets per day, taking 1 tablet every 6 to 8 hours. children under 4 years, consult your healthcare provider. initial dosage: adults and children 12 years and older: 1 tablet every 1/2 to 1 hour, until symptoms lessen, then continue with standard dosage. do not exceeed 12 tablets in 24 hours. children 4 to 11 years: 1 tablet every 1/2 to 1 hour, until symptoms lessen, then continue with standard dosage. do not exceed 8 tablets in 24 hours. children under 4 years, consult your healthcare provider. allow tablets to dissolve completely in the mouth, do not swallow.

Package Label Principal Display Panel:

Clearlife tablet.jpg


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.